MDL 001
Alternative Names: MDL-001Latest Information Update: 24 May 2022
At a glance
- Originator Model Medicines
- Class Antivirals; Small molecules
- Mechanism of Action RNA replicase inhibitors; Virus replication inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical COVID 2019 infections
- Research Influenza A virus H1N1 subtype
- Discontinued Unspecified
Most Recent Events
- 17 May 2022 Early research in Influenza A virus H1N1 subtype in USA (PO)
- 17 May 2022 Pharmacodynamics data from a preclinical study in COVID-2019 infections released by Model Medicines
- 17 May 2022 Pharmacodynamics data from a research study in Influenza A virus H1N1 subtype released by Model Medicines